{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:31:50Z","timestamp":1772159510306,"version":"3.50.1"},"reference-count":42,"publisher":"Portland Press Ltd.","issue":"18","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:p>Transthyretin (TTR)-related amyloidoses are diseases characterized by extracellular deposition of amyloid fibrils and aggregates in tissues composed of insoluble misfolded TTR that becomes toxic. Previous studies have demonstrated the ability of small compounds in preventing and reversing TTR V30M deposition in transgenic mice gastrointestinal (GI) tract as well as lowering biomarkers associated with cellular stress and apoptotic mechanisms. In the present study we aimed to study TTR V30M aggregates effect in autophagy, a cellular mechanism crucial for cell survival that has been implicated in the development of several neurodegenerative diseases. We were able to demonstrate in cell culture that TTR V30M aggregates cause a partial impairment of the autophagic machinery as shown by p62 accumulation, whereas early steps of the autophagic flux remain unaffected as shown by autophagosome number evaluation and LC3 turnover assay. Our studies performed in TTR V30M transgenic animals demonstrated that tauroursodeoxycholic acid (TUDCA) and curcumin effectively reverse p62 accumulation in the GI tract pointing to the ability of both compounds to modulate autophagy additionally to mitigate apoptosis. Overall, our in\u00a0vitro and in\u00a0vivo studies establish an association between TTR V30M aggregates and autophagy impairment and suggest the use of autophagy modulators as an additional and alternative therapeutic approach for the treatment of TTR V30M-related amyloidosis.<\/jats:p>","DOI":"10.1042\/cs20160075","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T01:19:19Z","timestamp":1467854359000},"page":"1665-1675","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impairment of autophagy by TTR V30M aggregates: <i>in\u00a0vivo<\/i> reversal by TUDCA and curcumin"],"prefix":"10.1042","volume":"130","author":[{"given":"Cristina\u00a0A.","family":"Teixeira","sequence":"first","affiliation":[{"name":"Instituto de Inova\u00e7\u00e3o e Investiga\u00e7\u00e3o em Sa\u00fade (I3S), Universidade do Porto, Porto 4200-135, Portugal"},{"name":"Unidade de Neurobiologia Molecular, IBMC\u2013Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto 4200-135, Portugal"}]},{"given":"Maria do\u00a0Ros\u00e1rio","family":"Almeida","sequence":"additional","affiliation":[{"name":"Instituto de Inova\u00e7\u00e3o e Investiga\u00e7\u00e3o em Sa\u00fade (I3S), Universidade do Porto, Porto 4200-135, Portugal"},{"name":"Unidade de Neurobiologia Molecular, IBMC\u2013Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto 4200-135, Portugal"},{"name":"Departamento de Biologia Molecular, ICBAS\u2013Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, Universidade do Porto, Porto 4050-313, Portugal"}]},{"given":"Maria\u00a0Jo\u00e3o","family":"Saraiva","sequence":"additional","affiliation":[{"name":"Instituto de Inova\u00e7\u00e3o e Investiga\u00e7\u00e3o em Sa\u00fade (I3S), Universidade do Porto, Porto 4200-135, Portugal"},{"name":"Unidade de Neurobiologia Molecular, IBMC\u2013Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto 4200-135, Portugal"}]}],"member":"288","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"2021113010441877800_B1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/bi00542a009","article-title":"Binding of thyroid hormones and analogues to the human plasma protein prealbumin","volume":"19","author":"Andrea","year":"1980","journal-title":"Biochemistry"},{"key":"2021113010441877800_B2","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1172\/JCI112224","article-title":"Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant","volume":"76","author":"Saraiva","year":"1985","journal-title":"J. Clin. Invest."},{"key":"2021113010441877800_B3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"2021113010441877800_B4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/bj3480167","article-title":"Designing transthyretin mutants affecting tetrameric structure: implications in amyloidogenicity","volume":"348","author":"Redondo","year":"2000","journal-title":"Biochem. J."},{"key":"2021113010441877800_B5","doi-asserted-by":"publisher","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants","volume":"276","author":"Quintas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021113010441877800_B6","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010441877800_B7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.abb.2013.03.005","article-title":"The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells","volume":"535","author":"Zhang","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"2021113010441877800_B8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.bbadis.2013.04.001","article-title":"Hepatic production of transthyretin L12P leads to intracellular lysosomal aggregates in a new somatic transgenic mouse model","volume":"1832","author":"Batista","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010441877800_B9","first-page":"2121","article-title":"Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy","volume":"8","author":"Li","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"2021113010441877800_B10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/labinvest.2013.83","article-title":"Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis","volume":"93","author":"Misumi","year":"2013","journal-title":"Lab. Invest."},{"key":"2021113010441877800_B11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/nrm2529","article-title":"Autophagic cell death: the story of a misnomer","volume":"9","author":"Kroemer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021113010441877800_B12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4161\/auto.5.5.8823","article-title":"In search of an \u201cautophagomometer\u201d","volume":"5","author":"Rubinsztein","year":"2009","journal-title":"Autophagy"},{"key":"2021113010441877800_B13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"2021113010441877800_B14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jviromet.2004.08.017","article-title":"Optimized large-scale production of high titer lentivirus vector pseudotypes","volume":"122","author":"Sena-Esteves","year":"2004","journal-title":"J. Virol. Methods"},{"key":"2021113010441877800_B15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","article-title":"Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of familial amyloidotic polyneuropathy","volume":"1782","author":"Macedo","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010441877800_B16","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1016\/j.febslet.2009.10.062","article-title":"Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity","volume":"583","author":"Ferreira","year":"2009","journal-title":"FEBS Lett."},{"key":"2021113010441877800_B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbadis.2012.10.007","article-title":"Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition","volume":"1832","author":"Ferreira","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010441877800_B18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/aps.2013.5","article-title":"Application and interpretation of current autophagy inhibitors and activators","volume":"34","author":"Yang","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"2021113010441877800_B19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4161\/auto.1.2.1697","article-title":"Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy","volume":"1","author":"Tanida","year":"2005","journal-title":"Autophagy"},{"key":"2021113010441877800_B20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/emboj.2009.29","article-title":"Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3","volume":"28","author":"Gamerdinger","year":"2009","journal-title":"EMBO J."},{"key":"2021113010441877800_B21","doi-asserted-by":"publisher","first-page":"26623","DOI":"10.1038\/srep26623","article-title":"Curcumin: a multi-target disease-modifying agent for late-stage transthyretin amyloidosis","volume":"6","author":"Ferreira","year":"2016","journal-title":"Sci. Rep."},{"key":"2021113010441877800_B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2627-5","article-title":"LC3-II Tagging and western blotting for monitoring autophagic activity in mammalian cells","volume":"1303","author":"Streeter","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"2021113010441877800_B23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40478-014-0177-8","article-title":"Glial cells in familial amyloidotic polyneuropathy","volume":"2","author":"Goncalves","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"2021113010441877800_B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/13506129.2013.787985","article-title":"Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis","volume":"20","author":"Wixner","year":"2013","journal-title":"Amyloid"},{"key":"2021113010441877800_B25","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol."},{"key":"2021113010441877800_B26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00019052-200410000-00012","article-title":"Liver transplantation in transthyretin-related familial amyloid polyneuropathy","volume":"17","author":"Stangou","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"2021113010441877800_B27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/13506129.2012.678508","article-title":"Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study","volume":"19","author":"Obici","year":"2012","journal-title":"Amyloid"},{"key":"2021113010441877800_B28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2174\/1573406411309070002","article-title":"Current prospects of synthetic curcumin analogs and chalcone derivatives against mycobacterium tuberculosis","volume":"9","author":"Bukhari","year":"2013","journal-title":"Med. Chem."},{"key":"2021113010441877800_B29","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1021\/jf501145b","article-title":"Biological activity and molecular docking studies of curcumin-related alpha,beta-unsaturated carbonyl-based synthetic compounds as anticancer agents and mushroom tyrosinase inhibitors","volume":"62","author":"Bukhari","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"2021113010441877800_B30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.2042-7158.2011.01423.x","article-title":"Effects of diarylpentanoid analogues of curcumin on chemiluminescence and chemotactic activities of phagocytes","volume":"64","author":"Jantan","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"2021113010441877800_B31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1124\/mol.106.033167","article-title":"Evidence that curcumin suppresses the growth of malignant gliomas in\u00a0vitro and in\u00a0vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways","volume":"72","author":"Aoki","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"2021113010441877800_B32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis","volume":"13","author":"Sekijima","year":"2006","journal-title":"Amyloid"},{"key":"2021113010441877800_B33","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010441877800_B34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"2021113010441877800_B35","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/sj.gt.3302228","article-title":"Targeted conversion of the transthyretin gene in\u00a0vitro and in\u00a0vivo","volume":"11","author":"Nakamura","year":"2004","journal-title":"Gene Ther."},{"key":"2021113010441877800_B36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1096\/fj.05-4509com","article-title":"Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model","volume":"20","author":"Cardoso","year":"2006","journal-title":"FASEB J."},{"key":"2021113010441877800_B37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering transthyretin deposition and associated biomarkers: studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J. Transl. Med."},{"key":"2021113010441877800_B38","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"2021113010441877800_B39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2021113010441877800_B40","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021113010441877800_B41","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"2021113010441877800_B42","doi-asserted-by":"publisher","first-page":"e25416","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/18\/1665\/448102\/cs1301665.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/18\/1665\/448102\/cs1301665.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:33:01Z","timestamp":1638271981000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/130\/18\/1665\/71452\/Impairment-of-autophagy-by-TTR-V30M-aggregates-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":42,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20160075","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]}}}